TY - JOUR AU - Andreyev, J. AU - Ross, P. AU - Donnellan, C. PY - 2014 DA - 2014// TI - Guidance on the management of diarrhoea during cancer chemotherapy JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70006-3 DO - 10.1016/S1470-2045(14)70006-3 ID - Andreyev2014 ER - TY - JOUR AU - Mcquade, R. M. AU - Stojanovska, V. AU - Abalo, R. PY - 2016 DA - 2016// TI - Chemotherapy-induced constipation and diarrhea: Pathophysiology, Current and Emerging Treatments JO - Front Pharmacol VL - 7 UR - https://doi.org/10.3389/fphar.2016.00414 DO - 10.3389/fphar.2016.00414 ID - Mcquade2016 ER - TY - JOUR AU - Benson, A. R. AU - Ajani, J. A. AU - Catalano, R. B. PY - 2004 DA - 2004// TI - Recommended guidelines for the treatment of cancer treatment-induced diarrhea JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.04.132 DO - 10.1200/JCO.2004.04.132 ID - Benson2004 ER - TY - JOUR AU - Stein, A. AU - Voigt, W. AU - Jordan, K. PY - 2010 DA - 2010// TI - Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management JO - Ther Adv Med Oncol VL - 2 UR - https://doi.org/10.1177/1758834009355164 DO - 10.1177/1758834009355164 ID - Stein2010 ER - TY - JOUR AU - Maroun, J. A. AU - Anthony, L. B. AU - Blais, N. PY - 2007 DA - 2007// TI - Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea JO - Curr Oncol VL - 14 UR - https://doi.org/10.3747/co.2007.96 DO - 10.3747/co.2007.96 ID - Maroun2007 ER - TY - JOUR AU - Li, M. AU - Wang, Z. AU - Guo, J. PY - 2014 DA - 2014// TI - Clinical significance of UGT1A1 gene polymorphisms on irinotecan-based regimens as the treatment in metastatic colorectal cancer JO - Onco Targets Ther. VL - 7 ID - Li2014 ER - TY - JOUR AU - Fernandes, C. AU - Wanderley, C. AU - Silva, C. PY - 2018 DA - 2018// TI - Role of regulatory T cells in irinotecan-induced intestinal mucositis JO - Eur J Pharm Sci VL - 115 UR - https://doi.org/10.1016/j.ejps.2018.01.006 DO - 10.1016/j.ejps.2018.01.006 ID - Fernandes2018 ER - TY - JOUR AU - Xu, C. AU - Tang, X. AU - Qu, Y. PY - 2016 DA - 2016// TI - UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer JO - Cancer Chemother Pharmacol VL - 78 UR - https://doi.org/10.1007/s00280-016-3057-z DO - 10.1007/s00280-016-3057-z ID - Xu2016 ER - TY - JOUR AU - Peng, H. AU - Duan, Z. AU - Pan, D. PY - 2017 DA - 2017// TI - UGT1A1 Gene polymorphism predicts irinotecan-induced severe neutropenia and diarrhea in Chinese cancer patients JO - Clin Lab VL - 63 ID - Peng2017 ER - TY - JOUR AU - Hoff, P. M. AU - Saragiotto, D. F. AU - Barrios, C. H. PY - 2014 DA - 2014// TI - Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.50.8077 DO - 10.1200/JCO.2013.50.8077 ID - Hoff2014 ER - TY - JOUR AU - Barbounis, V. AU - Koumakis, G. AU - Vassilomanolakis, M. PY - 2001 DA - 2001// TI - Control of irinotecan-induced diarrhea by octreotide after loperamide failure JO - Support Care Cancer VL - 9 UR - https://doi.org/10.1007/s005200000220 DO - 10.1007/s005200000220 ID - Barbounis2001 ER - TY - JOUR AU - Marraffa, J. M. AU - Holland, M. G. AU - Sullivan, R. W. PY - 2014 DA - 2014// TI - Cardiac conduction disturbance after loperamide abuse [J] JO - Clin Toxicol (Phila) VL - 52 UR - https://doi.org/10.3109/15563650.2014.969371 DO - 10.3109/15563650.2014.969371 ID - Marraffa2014 ER - TY - JOUR AU - Upadhyay, A. AU - Bodar, V. AU - Malekzadegan, M. PY - 2016 DA - 2016// TI - Loperamide induced life threatening ventricular arrhythmia JO - Case Rep Cardiol VL - 2016 ID - Upadhyay2016 ER - TY - JOUR AU - Peng, G. AU - Guan, H. AU - Wang, X. PY - 2017 DA - 2017// TI - Simultaneous determination of 14 active constituents of Shengjiang Xiexin decoction using ultrafast liquid chromatography coupled with electrospray ionization tandem mass spectrometry JO - Acta Pharm Sin B VL - 7 UR - https://doi.org/10.1016/j.apsb.2016.11.006 DO - 10.1016/j.apsb.2016.11.006 ID - Peng2017 ER - TY - JOUR AU - Deng, B. AU - Jia, L. AU - Tan, H. PY - 2017 DA - 2017// TI - Effects of Shengjiangxiexin decoction on irinotecan-induced toxicity in patients with UGT1A1*28 and UGT1A1*6 polymorphisms JO - J Tradit Chin Med VL - 37 UR - https://doi.org/10.1016/S0254-6272(17)30024-9 DO - 10.1016/S0254-6272(17)30024-9 ID - Deng2017 ER - TY - JOUR AU - Deng, C. AU - Deng, B. AU - Jia, L. PY - 2017 DA - 2017// TI - Preventive effects of a Chinese herbal formula, Shengjiang Xiexin decoction, on irinotecan-induced delayed-onset diarrhea in rats JO - Evid Based Complement Alternat Med VL - 2017 ID - Deng2017 ER - TY - JOUR AU - Guan, H. Y. AU - Li, P. F. AU - Wang, X. M. PY - 2017 DA - 2017// TI - Shengjiang Xiexin decoction alters pharmacokinetics of irinotecan by regulating metabolic enzymes and transporters: a multi-target therapy for alleviating the gastrointestinal toxicity JO - Front Pharmacol VL - 8 UR - https://doi.org/10.3389/fphar.2017.00769 DO - 10.3389/fphar.2017.00769 ID - Guan2017 ER - TY - JOUR AU - Satouchi, M. AU - Kotani, Y. AU - Shibata, T. PY - 2014 DA - 2014// TI - Phase III study comparing amrubicin plus cisplatin with irinotecan plus cisplatin in the treatment of extensive-disease small-cell lung cancer: JCOG 0509 JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.53.5153 DO - 10.1200/JCO.2013.53.5153 ID - Satouchi2014 ER - TY - JOUR AU - Wang, X. F. AU - Ma, C. AU - Gong, F. F. PY - 2018 DA - 2018// TI - Relationship between UGT1A1 gene polymorphisms and irinotecan-induced severe adverse events JO - Zhonghua Zhong Liu Za Zhi VL - 40 ID - Wang2018 ER - TY - JOUR AU - Wang, Y. AU - Yi, C. AU - Wang, Y. PY - 2017 DA - 2017// TI - Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancer JO - Oncol Lett VL - 14 ID - Wang2017 ER - TY - JOUR AU - Chen, C. AU - Tao, C. AU - Liu, Z. PY - 2015 DA - 2015// TI - A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome JO - Phytother Res VL - 29 UR - https://doi.org/10.1002/ptr.5475 DO - 10.1002/ptr.5475 ID - Chen2015 ER - TY - JOUR AU - Bharucha, A. E. AU - Wouters, M. M. AU - Tack, J. PY - 2017 DA - 2017// TI - Existing and emerging therapies for managing constipation and diarrhea JO - Curr Opin Pharmacol VL - 37 UR - https://doi.org/10.1016/j.coph.2017.10.015 DO - 10.1016/j.coph.2017.10.015 ID - Bharucha2017 ER - TY - JOUR AU - Liu, Z. L. AU - Wang, B. AU - Liu, J. Z. PY - 2018 DA - 2018// TI - Irinotecan plus cisplatin compared with etoposide plus cisplatin in patients with previously untreated extensive-stage small cell lung cancer: a meta-analysis [J] JO - J Cancer Res Ther VL - 14 ID - Liu2018 ER - TY - JOUR AU - Tarricone, R. AU - Abu, K. D. AU - Nyanzi-Wakholi, B. PY - 2016 DA - 2016// TI - A systematic literature review of the economic implications of chemotherapy-induced diarrhea and its impact on quality of life JO - Crit Rev Oncol Hematol VL - 99 UR - https://doi.org/10.1016/j.critrevonc.2015.12.012 DO - 10.1016/j.critrevonc.2015.12.012 ID - Tarricone2016 ER - TY - JOUR AU - Ohnishi, S. AU - Takeda, H. PY - 2015 DA - 2015// TI - Herbal medicines for the treatment of cancer chemotherapy-induced side effects JO - Front Pharmacol VL - 6 UR - https://doi.org/10.3389/fphar.2015.00014 DO - 10.3389/fphar.2015.00014 ID - Ohnishi2015 ER - TY - JOUR AU - Lu, H. AU - Qin, J. AU - Han, N. PY - 2018 DA - 2018// TI - Banxia Xiexin decoction is effective to prevent and control irinotecan-induced delayed diarrhea in recurrent small cell lung cancer JO - Integr Cancer Ther VL - 17 UR - https://doi.org/10.1177/1534735418801532 DO - 10.1177/1534735418801532 ID - Lu2018 ER - TY - JOUR AU - Kummar, S. AU - Copur, M. S. AU - Rose, M. PY - 2011 DA - 2011// TI - A phase I study of the Chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer JO - Clin Colorectal Cancer VL - 10 UR - https://doi.org/10.1016/j.clcc.2011.03.003 DO - 10.1016/j.clcc.2011.03.003 ID - Kummar2011 ER - TY - JOUR AU - Xiao, X. G. AU - Xia, S. AU - Zou, M. PY - 2015 DA - 2015// TI - The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer JO - Onco Targets Ther. VL - 8 UR - https://doi.org/10.2147/OTT.S95149 DO - 10.2147/OTT.S95149 ID - Xiao2015 ER - TY - JOUR AU - Liu, X. H. AU - Lu, J. AU - Duan, W. PY - 2017 DA - 2017// TI - Predictive value of UGT1A1*28 polymorphism in irinotecan-based chemotherapy JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.17210 DO - 10.7150/jca.17210 ID - Liu2017 ER - TY - JOUR AU - Bai, Y. AU - Wu, H. W. AU - Ma, X. PY - 2017 DA - 2017// TI - Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy JO - Onco Targets Ther VL - 10 UR - https://doi.org/10.2147/OTT.S137644 DO - 10.2147/OTT.S137644 ID - Bai2017 ER - TY - JOUR AU - Gao, J. AU - Zhou, J. AU - Li, Y. PY - 2013 DA - 2013// TI - UGT1A1 6/28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-013-0604-x DO - 10.1007/s12032-013-0604-x ID - Gao2013 ER -